James Molloy's Stock Ratings

Alliance Global Partners Analyst

James Molloy is an analyst at Alliance Global Partners. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 02/23/2025

Overall Average Return

-38.4%

Smart Score

31.9%

Overall Average Return Percentile

4th

Number of Ratings

44
Data brought to you by Benzinga APIs

Recent Analyst Stock Rating News

This GeoVax Labs Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Monday
The Analyst Verdict: IGC Pharma In The Eyes Of 4 Experts
Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.<
Why Ampio Pharmaceuticals Stock Is Rising Today
Ampio Pharmaceuticals Inc (AMEX:AMPE) shares are trading significantly higher Thursday following bullish analyst coverage. Alliance Global Partners analyst James Molloy initiated coverage on Ampio Pharmaceuticals with a Buy rating and announced a $4.50 price target, which is well above current levels.
Under Armour Preview: Will The Warm Winter Hurt Earnings?
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2025 Benzinga | All Rights Reserved